Serial Number
90860167
Owner
Liling biopharmaceuticals (Suzhou) Co., LtdFirst Use Date
Jul 31, 2021
Filing Date
Aug 2, 2021
LEALING BIOPHARMA Trademark
Serial Number: 90860167 • Registration: 6825724
Trademark Classes
Owner Contact Info
Room 502, Building 1, Shunda Commercial
Jiangsu 215000 , CN
Entity Type: 99
Legal Representation
Correspondence Address
Liling biopharmaceuticals (Suzhou) Co., Ltd
Room 502, Building 1, Shunda Commercial
Plaza, Suzhou Industrial Park,
Jiangsu, 215000
CHINA
Trademark Details
Filing Date
August 2, 2021
Registration Date
August 23, 2022
First Use Anywhere
July 31, 2021
First Use in Commerce
July 31, 2021
Published for Opposition
June 7, 2022
Goods & Services
Immunostimulants; Biological preparations for the treatment of cancer; Biological preparations for the treatment of infectious diseases; Disinfecting wipes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents